Filing Flows › AbbVie (ABBV) › Who owns the stock
Who owns AbbVie (ABBV) stock
4,119 funds reported AbbVie (ABBV) shares in their latest 13F filings, worth $352.7B in all. The largest holder is Vanguard Group ($41.3B). Last quarter 1,970 funds added to their stakes and 1497 cut them. Members of Congress and other officials disclosed 7 trades (1 buys, 6 sales).
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Vanguard Group | 180,779,699 | $41.3B | increase | 2025-12-31 |
| BlackRock | 149,488,412 | $37.6B | decrease | 2026-06-30 |
| Vanguard Capital Management LLC | 115,396,098 | $29.0B | increase | 2026-06-30 |
| State Street | 82,596,748 | $20.8B | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 48,477,996 | $12.2B | decrease | 2026-06-30 |
| Geode Capital Management, LLC | 46,998,433 | $11.8B | increase | 2026-06-30 |
| Morgan Stanley | 38,901,001 | $9.8B | increase | 2026-06-30 |
| Capital Research Global Investors | 30,101,551 | $7.6B | decrease | 2026-06-30 |
| Bank of America | 21,237,764 | $5.3B | decrease | 2026-06-30 |
| FMR LLC | 20,773,786 | $5.2B | decrease | 2026-06-30 |
| Northern Trust | 20,558,447 | $5.2B | decrease | 2026-06-30 |
| Franklin Resources | 19,925,232 | $5.0B | increase | 2026-06-30 |
| Capital World Investors | 19,178,966 | $4.8B | increase | 2026-06-30 |
| Goldman Sachs Group | 16,291,630 | $4.1B | increase | 2026-06-30 |
| Capital International Investors | 15,638,631 | $3.9B | increase | 2026-06-30 |
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2026-09-14 | Pete Sessions | sale | $15K–$50K |
| 2026-05-05 | Josh Gottheimer | sale | $1K–$15K |
| 2026-03-27 | Alan Armstrong | purchase | $15K–$50K |
| 2025-12-18 | Julie Johnson | sale | $1K–$15K |
| 2025-12-08 | Julia Letlow | sale | $1K–$15K |
| 2025-11-13 | Julie Johnson | partial sale | $1K–$15K |
| 2025-10-31 | Lisa McClain | sale | $1K–$15K |
AbbVie's latest quarter
AbbVie, Q3 2026: revenue $17.4B (+10% year over year), operating margin 36.0%, net earnings $4.2B, operating cash flow $7.6B. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most ABBV stock?
By the latest 13F filings: Vanguard Group ($41.3B); BlackRock ($37.6B); Vanguard Capital Management LLC ($29.0B); State Street ($20.8B); Vanguard Portfolio Management LLC ($12.2B).
Has Congress traded ABBV stock?
Officials disclosed 7 trades on file: 1 buys and 6 sales. The latest: Pete Sessions, sale on 2026-09-14.
What is the short interest in ABBV?
15,582,821 shares were sold short at the 2026-10-15 settlement, -4.29% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.